- Cipla has received final approval from the USFDA for its Abbreviated New Drug Application for Protein-bound Paclitaxel.
- This drug is a generic version of Bristol Myers Squibb’s Abraxa…
Join the vibrant privacy-ensured Dzambhala community on
Want to give feedback on this story? Write to us at [email protected]